The battle over the legalities of cannabidiol (CBD) oil has been going on for years. The fight has been tough, and the casualties brutal. Some say the general public should be allowed to utilize CBD oil, and others say it should only be entrusted to big pharmacies. In the midst of it all, the question regarding the exact origin of CBD oil and its relation to marijuana seems to puzzle even the best of us. Recently the federal court ruled against CBD, making a clear statement that, to no surprise, the U.S. government seems to be in favor of big pharma.
The Federal Court Ruled Against CBD Extract
In August 2018 the hemp industry lost an important appeal that is negatively impacting the availability of CBD oil today. The federal court ruled against CBD and sided with the Drug Enforcement Administration (DEA) in their decision to categorize CBD as a Schedule I substance under the Controlled Substances Act. In other words, the federal court believes CBD oil has no medicinal value, is not considered safe for general consumption, and should be under the same legal limitations as marijuana and heroin. (6)…
How is it possible that the DEA is a party to a lawsuit which affects their own administrative domain? Wouldn’t it be nice to write your own job description? DEA: “But it’s our job to throw people in jail and steal their homes and vehicles for no reason! You don’t want to put us out of a job do you? And while we’re at it, why not make vitamin C a controlled substance too?”